Leflutrozole - ReproNovo
Alternative Names: BGS-649Latest Information Update: 15 Jan 2024
At a glance
- Originator Novartis
- Developer Mereo BioPharma; Novartis
- Class Antihormones; Benzonitrile; Small molecules; Triazoles
- Mechanism of Action Aromatase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Hypogonadism
- Discontinued Endometriosis